30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Turning Point Therapeutics Inc (TPTX)

Track

Stock chart
Ticker: TPTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
TOMBESI PAOLO
EVP & Chief Financial Officer
1 sale — total 88,654 USD
Sale 27 Jul 2022
Value US$2,469,758.44 | Price 423.71 | Shares 96,237
Sale 9 Feb 2022
Value US$932,808.95 | Price 184.10 | Shares 54,853
Planned sale 9 Feb 2022
Value US$107,847.30 | Price 36.30 | Shares 2,971
Planned sale 9 Feb 2022
Value US$8,022.30 | Price 36.30 | Shares 221
Sale 9 Feb 2022
Value US$14,411.10 | Price 36.30 | Shares 397
Planned sale 9 Feb 2022
Value US$24,284.70 | Price 36.30 | Shares 669
Planned sale 15 Jun 2021
Value US$516,257.88 | Price 77.82 | Shares 6,634
Planned sale 15 Jun 2021
Value US$208,899.00 | Price 77.37 | Shares 2,700
Planned sale 15 Jun 2021
Value US$430,276.04 | Price 75.94 | Shares 5,666
Planned sale 23 Mar 2021
Value US$10,417.00 | Price 104.17 | Shares 100
Planned sale 23 Mar 2021
Value US$400,047.60 | Price 102.84 | Shares 3,890
Planned sale 23 Mar 2021
Value US$824,076.03 | Price 102.23 | Shares 8,061
Planned sale 23 Mar 2021
Value US$505,909.80 | Price 100.98 | Shares 5,010
Planned sale 23 Mar 2021
Value US$199,739.72 | Price 100.07 | Shares 1,996
Planned sale 23 Mar 2021
Value US$440,370.84 | Price 98.76 | Shares 4,459
Planned sale 23 Mar 2021
Value US$481,520.91 | Price 97.89 | Shares 4,919
Planned sale 8 Mar 2021
Value US$78,183.00 | Price 111.69 | Shares 700
Planned sale 8 Mar 2021
Value US$506,329.67 | Price 110.77 | Shares 4,571
Planned sale 8 Mar 2021
Value US$1,035,053.91 | Price 109.89 | Shares 9,419
Planned sale 8 Mar 2021
Value US$524,722.90 | Price 109.09 | Shares 4,810
Planned sale 8 Mar 2021
Value US$51,650.00 | Price 103.30 | Shares 500
Planned sale 4 Mar 2021
Value US$66,876.00 | Price 111.46 | Shares 600
Planned sale 4 Mar 2021
Value US$77,413.00 | Price 110.59 | Shares 700
Planned sale 4 Mar 2021
Value US$77,006.44 | Price 108.92 | Shares 707
Planned sale 4 Mar 2021
Value US$396,780.15 | Price 107.85 | Shares 3,679
Planned sale 4 Mar 2021
Value US$719,485.08 | Price 107.13 | Shares 6,716
Planned sale 4 Mar 2021
Value US$328,018.13 | Price 105.71 | Shares 3,103
Planned sale 4 Mar 2021
Value US$209,940.00 | Price 104.97 | Shares 2,000
Planned sale 4 Mar 2021
Value US$644,703.00 | Price 103.65 | Shares 6,220
Planned sale 4 Mar 2021
Value US$907,313.40 | Price 102.87 | Shares 8,820
Planned sale 4 Mar 2021
Value US$306,540.05 | Price 102.01 | Shares 3,005
Planned sale 11 Feb 2021
Value US$422,854.60 | Price 138.55 | Shares 3,052
Planned sale 11 Feb 2021
Value US$216,263.86 | Price 137.66 | Shares 1,571
Planned sale 11 Feb 2021
Value US$589,327.55 | Price 136.45 | Shares 4,319
Planned sale 10 Feb 2021
Value US$59,836.27 | Price 138.19 | Shares 433
Planned sale 10 Feb 2021
Value US$286,054.26 | Price 137.46 | Shares 2,081
Planned sale 10 Feb 2021
Value US$2,268,118.92 | Price 136.42 | Shares 16,626
Planned sale 10 Feb 2021
Value US$709,408.44 | Price 135.72 | Shares 5,227
Planned sale 10 Feb 2021
Value US$137,698.50 | Price 134.34 | Shares 1,025
Planned sale 9 Feb 2021
Value US$154,824.96 | Price 140.24 | Shares 1,104
Planned sale 9 Feb 2021
Value US$1,856,480.10 | Price 139.69 | Shares 13,290
Planned sale 9 Feb 2021
Value US$689,001.54 | Price 138.66 | Shares 4,969
Planned sale 9 Feb 2021
Value US$14,170.74 | Price 137.58 | Shares 103
Planned sale 9 Feb 2021
Value US$844,998.00 | Price 136.29 | Shares 6,200
Planned sale 2 Feb 2021
Value US$139,238.61 | Price 131.73 | Shares 1,057
Planned sale 2 Feb 2021
Value US$948,924.86 | Price 130.58 | Shares 7,267
Planned sale 2 Feb 2021
Value US$593,705.20 | Price 129.80 | Shares 4,574
Planned sale 2 Feb 2021
Value US$51,364.00 | Price 128.41 | Shares 400
Planned sale 2 Feb 2021
Value US$127,580.00 | Price 127.58 | Shares 1,000
Planned sale 2 Feb 2021
Value US$79,661.56 | Price 131.89 | Shares 604
Planned sale 2 Feb 2021
Value US$490,161.28 | Price 130.64 | Shares 3,752
Planned sale 2 Feb 2021
Value US$371,085.00 | Price 129.75 | Shares 2,860
Planned sale 2 Feb 2021
Value US$64,370.00 | Price 128.74 | Shares 500
Planned sale 2 Feb 2021
Value US$115,047.00 | Price 127.83 | Shares 900
Planned sale 2 Feb 2021
Value US$50,664.00 | Price 126.66 | Shares 400
Planned sale 1 Feb 2021
Value US$25,214.00 | Price 126.07 | Shares 200
Planned sale 1 Feb 2021
Value US$267,017.80 | Price 124.60 | Shares 2,143
Planned sale 1 Feb 2021
Value US$1,060,851.20 | Price 123.70 | Shares 8,576
Planned sale 1 Feb 2021
Value US$588,022.02 | Price 122.94 | Shares 4,783
Planned sale 1 Feb 2021
Value US$62,690.00 | Price 125.38 | Shares 500
Planned sale 1 Feb 2021
Value US$412,170.33 | Price 124.41 | Shares 3,313
Planned sale 1 Feb 2021
Value US$1,301,708.09 | Price 123.49 | Shares 10,541
Planned sale 1 Feb 2021
Value US$199,805.40 | Price 122.58 | Shares 1,630
Planned sale 7 Jan 2021
Value US$63,109.26 | Price 123.02 | Shares 513
Planned sale 7 Jan 2021
Value US$2,672,253.00 | Price 122.44 | Shares 21,825
Planned sale 7 Jan 2021
Value US$632,164.00 | Price 121.57 | Shares 5,200
Planned sale 7 Jan 2021
Value US$108,144.00 | Price 120.16 | Shares 900
Planned sale 7 Jan 2021
Value US$343,420.00 | Price 122.65 | Shares 2,800
Planned sale 5 Jan 2021
Value US$150,360.00 | Price 120.00 | Shares 1,253
Planned sale 4 Jan 2021
Value US$1,053,313.74 | Price 120.42 | Shares 8,747
Planned sale 4 Jan 2021
Value US$36,732.00 | Price 122.44 | Shares 300
Planned sale 9 Jun 2020
Value US$20,244.00 | Price 67.48 | Shares 300
Planned sale 9 Jun 2020
Value US$172,161.00 | Price 66.60 | Shares 2,585
Planned sale 9 Jun 2020
Value US$297,087.00 | Price 65.80 | Shares 4,515
Planned sale 9 Jun 2020
Value US$109,416.16 | Price 64.82 | Shares 1,688
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-29 2022-07-27 S Sale
TOMBESI PAOLO

EVP & Chief Financial Officer

Officer
96,237 -16.1%
423.71
US$2,469,758 		96,237 -16.1% 423.71 US$2,469,758
2022-02-11 2022-02-09 S Sale
North Annette

EVP & General Counsel

Officer
54,853 +26.5%
184.10
US$932,809 		54,853 +26.5% 184.10 US$932,809
2022-02-11 2022-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
50,023 -29.1%
427.39
US$4,730,456 		50,023 -29.1% 427.39 US$4,730,456
2022-02-11 2022-02-09 PlS Planned sale
Partridge Andrew John

EVP & Chief Commercial Officer

Officer
221 -1.0%
36.30
US$8,022 		221 -1.0% 36.30 US$8,022
2022-02-11 2022-02-09 S Sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
397 -10.3%
36.30
US$14,411 		397 -10.3% 36.30 US$14,411
2022-02-11 2022-02-09 PlS Planned sale
Hirmand Mohammad

EVP & Chief Medical Officer

Officer
669 -8.9%
36.30
US$24,285 		669 -8.9% 36.30 US$24,285
2021-06-16 2021-06-15 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
6,634 -34.9%
77.82
US$516,258 		6,634 -34.9% 77.82 US$516,258
2021-06-16 2021-06-15 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
2,700 -12.4%
77.37
US$208,899 		2,700 -12.4% 77.37 US$208,899
2021-06-16 2021-06-15 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
5,666 -20.7%
75.94
US$430,276 		5,666 -20.7% 75.94 US$430,276
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
100 -2.4%
104.17
US$10,417 		100 -2.4% 104.17 US$10,417
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
3,890 -48.0%
102.84
US$400,048 		3,890 -48.0% 102.84 US$400,048
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
8,061 -49.9%
102.23
US$824,076 		8,061 -49.9% 102.23 US$824,076
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
5,010 -23.7%
100.98
US$505,910 		5,010 -23.7% 100.98 US$505,910
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
1,996 -8.6%
100.07
US$199,740 		1,996 -8.6% 100.07 US$199,740
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
4,459 -16.1%
98.76
US$440,371 		4,459 -16.1% 98.76 US$440,371
2021-03-24 2021-03-23 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
4,919 -15.1%
97.89
US$481,521 		4,919 -15.1% 97.89 US$481,521
2021-03-09 2021-03-08 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
700 -9.7%
111.69
US$78,183 		700 -9.7% 111.69 US$78,183
2021-03-09 2021-03-08 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
4,571 -38.9%
110.77
US$506,330 		4,571 -38.9% 110.77 US$506,330
2021-03-09 2021-03-08 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
9,419 -44.5%
109.89
US$1,035,054 		9,419 -44.5% 109.89 US$1,035,054
2021-03-09 2021-03-08 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
4,810 -18.5%
109.09
US$524,723 		4,810 -18.5% 109.09 US$524,723
2021-03-09 2021-03-08 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
500 -1.9%
103.30
US$51,650 		500 -1.9% 103.30 US$51,650
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
600 -13.5%
111.46
US$66,876 		600 -13.5% 111.46 US$66,876
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
700 -13.6%
110.59
US$77,413 		700 -13.6% 110.59 US$77,413
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
707 -12.1%
108.92
US$77,006 		707 -12.1% 108.92 US$77,006
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
3,679 -38.6%
107.85
US$396,780 		3,679 -38.6% 107.85 US$396,780
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
6,716 -41.3%
107.13
US$719,485 		6,716 -41.3% 107.13 US$719,485
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
3,103 -16.0%
105.71
US$328,018 		3,103 -16.0% 105.71 US$328,018
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
2,000 -9.4%
104.97
US$209,940 		2,000 -9.4% 104.97 US$209,940
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
6,220 -22.6%
103.65
US$644,703 		6,220 -22.6% 103.65 US$644,703
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
8,820 -24.2%
102.87
US$907,313 		8,820 -24.2% 102.87 US$907,313
2021-03-05 2021-03-04 PlS Planned sale
Reich Siegfried

EVP & Chief Scientific Officer

Officer
3,005 -7.6%
102.01
US$306,540 		3,005 -7.6% 102.01 US$306,540
2021-02-11 2021-02-11 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
3,052 -5.7%
138.55
US$422,855 		3,052 -5.7% 138.55 US$422,855
2021-02-11 2021-02-11 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
1,571 -2.9%
137.66
US$216,264 		1,571 -2.9% 137.66 US$216,264
2021-02-11 2021-02-11 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
4,319 -7.3%
136.45
US$589,328 		4,319 -7.3% 136.45 US$589,328
2021-02-11 2021-02-10 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
433 -0.9%
138.19
US$59,836 		433 -0.9% 138.19 US$59,836
2021-02-11 2021-02-10 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
2,081 -3.9%
137.46
US$286,054 		2,081 -3.9% 137.46 US$286,054
2021-02-11 2021-02-10 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
16,626 -24.0%
136.42
US$2,268,119 		16,626 -24.0% 136.42 US$2,268,119
2021-02-11 2021-02-10 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
5,227 -7.0%
135.72
US$709,408 		5,227 -7.0% 135.72 US$709,408
2021-02-11 2021-02-10 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
1,025 -1.4%
134.34
US$137,698 		1,025 -1.4% 134.34 US$137,698
2021-02-11 2021-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
1,104 -2.2%
140.24
US$154,825 		1,104 -2.2% 140.24 US$154,825
2021-02-11 2021-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
13,290 -20.6%
139.69
US$1,856,480 		13,290 -20.6% 139.69 US$1,856,480
2021-02-11 2021-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
4,969 -7.1%
138.66
US$689,002 		4,969 -7.1% 138.66 US$689,002
2021-02-11 2021-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
103 -0.1%
137.58
US$14,171 		103 -0.1% 137.58 US$14,171
2021-02-11 2021-02-09 PlS Planned sale
3.4
Countouriotis Athena

President & CEO

Executive Director
6,200 -8.2%
136.29
US$844,998 		6,200 -8.2% 136.29 US$844,998
2021-02-02 2021-02-02 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
1,057 -28.1%
131.73
US$139,239 		1,057 -28.1% 131.73 US$139,239
2021-02-02 2021-02-02 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
7,267 -65.9%
130.58
US$948,925 		7,267 -65.9% 130.58 US$948,925
2021-02-02 2021-02-02 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
4,574 -29.3%
129.80
US$593,705 		4,574 -29.3% 129.80 US$593,705
2021-02-02 2021-02-02 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
400 -2.5%
128.41
US$51,364 		400 -2.5% 128.41 US$51,364
2021-02-02 2021-02-02 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
1,000 -5.9%
127.58
US$127,580 		1,000 -5.9% 127.58 US$127,580
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
604 -100.0%
131.89
US$79,662 		604 -100.0% 131.89 US$79,662
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
3,752 -86.1%
130.64
US$490,161 		3,752 -86.1% 130.64 US$490,161
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
2,860 -39.6%
129.75
US$371,085 		2,860 -39.6% 129.75 US$371,085
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
500 -6.5%
128.74
US$64,370 		500 -6.5% 128.74 US$64,370
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
900 -10.4%
127.83
US$115,047 		900 -10.4% 127.83 US$115,047
2021-02-02 2021-02-02 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
400 -4.4%
126.66
US$50,664 		400 -4.4% 126.66 US$50,664
2021-02-02 2021-02-01 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
200 -6.9%
126.07
US$25,214 		200 -6.9% 126.07 US$25,214
2021-02-02 2021-02-01 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
2,143 -42.5%
124.60
US$267,018 		2,143 -42.5% 124.60 US$267,018
2021-02-02 2021-02-01 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
8,576 -63.0%
123.70
US$1,060,851 		8,576 -63.0% 123.70 US$1,060,851
2021-02-02 2021-02-01 PlS Planned sale
2.3
Larson Yi

EVP & Chief Financial Officer

Officer
4,783 -26.0%
122.94
US$588,022 		4,783 -26.0% 122.94 US$588,022
2021-02-02 2021-02-01 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
500 -100.0%
125.38
US$62,690 		500 -100.0% 125.38 US$62,690
2021-02-02 2021-02-01 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
3,313 -86.9%
124.41
US$412,170 		3,313 -86.9% 124.41 US$412,170
2021-02-02 2021-02-01 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
10,541 -73.4%
123.49
US$1,301,708 		10,541 -73.4% 123.49 US$1,301,708
2021-02-02 2021-02-01 PlS Planned sale
North Annette

EVP, General Counsel & Secty.

Officer
1,630 -10.2%
122.58
US$199,805 		1,630 -10.2% 122.58 US$199,805
2021-01-08 2021-01-07 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
513 -33.7%
123.02
US$63,109 		513 -33.7% 123.02 US$63,109
2021-01-08 2021-01-07 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
21,825 -93.5%
122.44
US$2,672,253 		21,825 -93.5% 122.44 US$2,672,253
2021-01-08 2021-01-07 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
5,200 -18.2%
121.57
US$632,164 		5,200 -18.2% 121.57 US$632,164
2021-01-08 2021-01-07 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
900 -3.1%
120.16
US$108,144 		900 -3.1% 120.16 US$108,144
2021-01-08 2021-01-07 PlS Planned sale
Baker Brian Lee

SVP of Finance and Admin.

Officer
2,800 -8.7%
122.65
US$343,420 		2,800 -8.7% 122.65 US$343,420
2021-01-05 2021-01-05 PlS Planned sale
Hirmand Mohammad

EVP and Chief Medical Officer

Officer
1,253 -81.5%
120.00
US$150,360 		1,253 -81.5% 120.00 US$150,360
2021-01-05 2021-01-04 PlS Planned sale
Hirmand Mohammad

EVP and Chief Medical Officer

Officer
8,747 -96.9%
120.42
US$1,053,314 		8,747 -96.9% 120.42 US$1,053,314
2021-01-05 2021-01-04 PlS Planned sale
Hirmand Mohammad

EVP and Chief Medical Officer

Officer
300 -3.2%
122.44
US$36,732 		300 -3.2% 122.44 US$36,732
2020-06-10 2020-06-09 PlS Planned sale
Cui Jingrong Jean
Non-Executive Director
300 -0.1%
67.48
US$20,244 		300 -0.1% 67.48 US$20,244
2020-06-10 2020-06-09 PlS Planned sale
Cui Jingrong Jean
Non-Executive Director
2,585 -0.5%
66.60
US$172,161 		2,585 -0.5% 66.60 US$172,161
2020-06-10 2020-06-09 PlS Planned sale
Cui Jingrong Jean
Non-Executive Director
4,515 -0.8%
65.80
US$297,087 		4,515 -0.8% 65.80 US$297,087
2020-06-10 2020-06-09 PlS Planned sale
Cui Jingrong Jean
Non-Executive Director
1,688 -0.3%
64.82
US$109,416 		1,688 -0.3% 64.82 US$109,416
Explore more

More insider trading research around Turning Point Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America